Nasopharyngeal carcinoma secondary prevention

Jump to navigation Jump to search

Nasopharyngeal carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nasopharyngeal carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nasopharyngeal carcinoma secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nasopharyngeal carcinoma secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nasopharyngeal carcinoma secondary prevention

CDC on Nasopharyngeal carcinoma secondary prevention

Nasopharyngeal carcinoma secondary prevention in the news

Blogs on Nasopharyngeal carcinoma secondary prevention

Directions to Hospitals Treating Nasopharyngeal carcinoma

Risk calculators and risk factors for Nasopharyngeal carcinoma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]Faizan Sheraz, M.D. [3]

Overview

Secondary prevention measures of nasopharyneal cancer include routine physical examination and imaging at scheduled intervals after treatment. Dental screening and screening for thyroid cancers are recommended among patients who had received radiation therapy to the oral cavity and cervical region, respectively.

Secondary Prevention

Follow up after treatment

Patients treated for nasopharyngeal carcinoma should follow-up for secondary prevention. Follow-up measures are shown in the table below:[1][2]

Follow up Description
Physical exam
  • Every 1-3 months during the 1st year after treatment
  • Every 2-6 months during the 2nd year after treatment
  • Every 4-8 months between the 3rd and 5th years after treatment
  • Annually thereafter
Nasoendoscopy
Scanning
  • CT Scan
  • MRI

Scans are performed at routine intervals as follows:

Thyroid hormone testing
Dental screening

References

  1. Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ; et al. (2013). "Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines". J Natl Compr Canc Netw. 11 (8): 917–23. PMID 23946171.
  2. Chan, A. T. C.; Gregoire, V.; Lefebvre, J.- L.; Licitra, L.; Hui, E. P.; Leung, S. F.; Felip, E. (2012). "Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 23 (suppl 7): vii83–vii85. doi:10.1093/annonc/mds266. ISSN 0923-7534.


Template:WikiDoc Sources